Dysautonomia in the pathogenesis of migraine

References

• Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. 2015;35(17):6619–6629.
   PubMed Web of Science ®Google Scholar
• Stewart WF, Roy J, Lipton RB. Migraine prevalence, socioeconomic status, and social causation. Neurology. 2013;81(11):948–955.
   PubMed Web of Science ®Google Scholar
• Antonaci F, Ghiotto N, Wu S, et al. Recent advances in migraine therapy. Springerplus. 2016;5:637.
   PubMed Web of Science ®Google Scholar
• May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455–464.
   PubMed Web of Science ®Google Scholar
• Kojic Z, Stojanovic D. Pathophysiology of migraine–from molecular to personalized medicine. Med Pregl. 2013;66(1–2):53–57.
   PubMedGoogle Scholar
• Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97(2):553–622.
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol. 2012;15(Suppl 1):S15–S22.
   PubMed Web of Science ®Google Scholar
• Akerman S, Romero-Reyes M, Holland PR. Current and novel insights into the neurophysiology of migraine and its implications for therapeutics. Pharmacol Ther. 2017;172:151–170.
   PubMed Web of Science ®Google Scholar
• Rubin LS, Graham D, Pasker R, et al. Autonomic nervous system dysfunction in common migraine. Headache. 1985;25(1):40–48.
   PubMed Web of Science ®Google Scholar
• Wehrwein EA, Orer HS, Barman SM. Overview of the anatomy, physiology, and pharmacology of the autonomic nervous system. Compr Physiol. 2016;6(3):1239–1278.
   PubMed Web of Science ®Google Scholar
• Reichgott MJ. Clinical evidence of dysautonomia. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. Boston: Butterworths; 1990.
   Google Scholar
• Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009;10(6):397–409.
   PubMed Web of Science ®Google Scholar
• Akkermans R. Harold G Wolff. Lancet Neurol. 2015;14(10):982–983.
   PubMedGoogle Scholar
• Janig W. Relationship between pain and autonomic phenomena in headache and other pain conditions. Cephalalgia. 2003;23 Suppl 1:43–48.
   PubMed Web of Science ®Google Scholar
• Havanka-Kanniainen H, Tolonen U, Myllyla VV. Autonomic dysfunction in adult migraineurs. Headache. 1986;26(8):425–430.
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. Trigeminal autonomic cephalalgias: fancy term or constructive change to the IHS classification? J Neurol Neurosurg Psychiat. 2005;76(3):301–305.
   PubMed Web of Science ®Google Scholar
• Avnon Y, Nitzan M, Sprecher E, et al. Autonomic asymmetry in migraine: augmented parasympathetic activation in left unilateral migraineurs. Brain. 2004;127(Pt 9):2099–2108.
   PubMedGoogle Scholar
• Rabner J, Caruso A, Zurakowski D, et al. Autonomic dysfunction in pediatric patients with headache: migraine versus tension-type headache. Clin Auton Res. 2016;26(6):455–459.
   PubMed Web of Science ®Google Scholar
• Riesco N, Perez-Alvarez AI, Verano L, et al. Prevalence of cranial autonomic parasympathetic symptoms in chronic migraine: usefulness of a new scale. Cephalalgia. 2016;36(4):346–350.
   PubMed Web of Science ®Google Scholar
• Mirza AF, Mo J, Holt JL, et al. Is there a relationship between throbbing pain and arterial pulsations? J Neurosci. 2012;32(22):7572–7576.
   PubMed Web of Science ®Google Scholar
• Moulton EA, Becerra L, Johnson A, et al. Altered hypothalamic functional connectivity with autonomic circuits and the locus coeruleus in migraine. PLoS One. 2014;9(4):e95508.
   PubMed Web of Science ®Google Scholar
• Levy D, Strassman AM, Burstein R. A critical view on the role of migraine triggers in the genesis of migraine pain. Headache. 2009;49(6):953–957.
   PubMed Web of Science ®Google Scholar
• Tobaldini E, Costantino G, Solbiati M, et al. Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases. Neurosci Biobehav Rev. 2017;74(Pt B):321–329.
   PubMed Web of Science ®Google Scholar
• Engstrom M, Hagen K, Bjork M, et al. Sleep-related and non-sleep-related migraine: interictal sleep quality, arousals and pain thresholds. J Headache Pain. 2013;14:68.
   PubMedGoogle Scholar
• Maleki N, Becerra L, Borsook D. Migraine: maladaptive brain responses to stress. Headache. 2012;52 Suppl 2:102–106.
   PubMed Web of Science ®Google Scholar
• Patacchioli FR, Martelletti P. Neuroendocrine derangement in chronic migraine. Headache. 2006;46(8):1309–1310.
   PubMed Web of Science ®Google Scholar
• Borsook D, Maleki N, Becerra L, et al. Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load. Neuron. 2012;73(2):219–234.
   PubMed Web of Science ®Google Scholar
• McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998;840:33–44.
   PubMed Web of Science ®Google Scholar
• Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain. 2013;154 Suppl 1:S44–53.
   Web of Science ®Google Scholar
• Friberg L, Olesen J, Iversen HK, et al. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet. 1991;338(8758):13–17.
   PubMed Web of Science ®Google Scholar
• Levy D. Migraine pain, meningeal inflammation, and mast cells. Curr Pain Headache Rep. 2009;13(3):237–240.
   PubMed Web of Science ®Google Scholar
• Jansen-Olesen I, Baun M, Amrutkar DV, et al. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor. Neuropeptides. 2014;48(2):53–64.
   PubMed Web of Science ®Google Scholar
• Syed AU, Koide M, Braas KM, et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine. J Mol Neurosci. 2012;48(3):574–583.
   PubMed Web of Science ®Google Scholar
• Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache. 2004;44(1):53–64.
   PubMed Web of Science ®Google Scholar
• Lu W, Li B, Chen J, et al. Expression of calcitonin gene-related peptide, adenosine A2a receptor and adenosine A1 receptor in experiment rat migraine models. Biomed Rep. 2016;4(3):379–383.
   PubMed Web of Science ®Google Scholar
• Patwardhan AM, Vela J, Farugia J, et al. Trigeminal nociceptors express prostaglandin receptors. J Dent Res. 2008;87(3):262–266.
   PubMed Web of Science ®Google Scholar
• Hadjikhani N, Sanchez del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;98(8):4687–4692.
   PubMed Web of Science ®Google Scholar
• Erdener SE, Dalkara T. Modelling headache and migraine and its pharmacological manipulation. Br J Pharmacol. 2014;171(20):4575–4594.
   PubMed Web of Science ®Google Scholar
• Sarrouilhe D, Dejean C, Mesnil M. Involvement of gap junction channels in the pathophysiology of migraine with aura. Front Physiol. 2014;5:78.
   PubMed Web of Science ®Google Scholar
• Costa C, Tozzi A, Rainero I, et al. Cortical spreading depression as a target for anti-migraine agents. J Headache Pain. 2013;14.
   PubMed Web of Science ®Google Scholar
• Ahn AH. Southern headache society supplement: the neurobiology of throbbing pain in migraine. Headache. 2012;52 Suppl 1:12–14.
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen PC, Koehler PJ. History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward. Cephalalgia. 2008;28(8):877–886.
   PubMed Web of Science ®Google Scholar
• Asghar MS, Hansen AE, Kapijimpanga T, et al. Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology. 2010;75(17):1520–1526.
   PubMed Web of Science ®Google Scholar
• Limmroth V, May A, Auerbach P, et al. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. J Neurol Sci. 1996;138(1–2):60–65.
   PubMed Web of Science ®Google Scholar
• Goadsby PJ. All that is obvious is not clear: what is the origin of throbbing pain in migraine? Pain. 2013;154(7):970–971.
   PubMed Web of Science ®Google Scholar
• Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of RCBF in classic migraine. Ann Neurol. 1981;9(4):344–352.
   PubMed Web of Science ®Google Scholar
• Schoonman GG, Van der Grond J, Kortmann C, et al. Migraine headache is not associated with cerebral or meningeal vasodilatation - a 3T magnetic resonance angiography study. Brain. 2008;131:2192–2200.
   PubMed Web of Science ®Google Scholar
• Hansen JM, Sitarz J, Birk S, et al. Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers. Cephalalgia. 2006;26(11):1384–1484.
   Web of Science ®Google Scholar
• Rahmann A, Wienecke T, Hansen JM, et al. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia. 2008;28(3):226–236.
   PubMed Web of Science ®Google Scholar
• Schytz HW, Birk S, Wienecke T, et al. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain. 2009;132:16–25.
   PubMed Web of Science ®Google Scholar
• Kruuse C, Thomsen LL, Birk S, et al. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003;126:241–247.
   PubMed Web of Science ®Google Scholar
• Petersen KA, Birk S, Lassen LH, et al. The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia. 2005;25(2):139–147.
   PubMed Web of Science ®Google Scholar
• Farkkila M, Diener HC, Geraud G, et al. Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurol. 2012;11(5):405–413.
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Farkkila M, Reuter U, et al. Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan–a randomised proof-of-concept trial. Cephalalgia. 2010;30(10):1170–1178.
   PubMed Web of Science ®Google Scholar
• Nelson DL, Phebus LA, Johnson KW, et al. Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. Cephalalgia. 2010;30(10):1159–1169.
   PubMed Web of Science ®Google Scholar
• Aurora SK, Brin MF. Chronic migraine: an update on physiology, imaging, and the mechanism of action of two available pharmacologic therapies. Headache. 2017;57(1):109–125.
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Sholtzow M, Shaw JW, et al. Identifying cutaneous allodynia in chronic migraine using a practical clinical method. Cephalalgia. 2007;27(2):111–117.
   PubMed Web of Science ®Google Scholar
• Wang T, Chen N, Zhan W, et al. Altered effective connectivity of posterior thalamus in migraine with cutaneous allodynia: a resting-state fMRI study with Granger causality analysis. J Headache Pain. 2015;17:17.
   PubMedGoogle Scholar
• Tome-Pires C, Miro J. Electrodermal responses and memory recall in migraineurs and headache-free controls. Eur J Pain. 2014;18(9):1298–1306.
   PubMed Web of Science ®Google Scholar
• Yerdelen D, Acil T, Goksel B, et al. Heart rate recovery in migraine and tension-type headache. Headache. 2008;48(2):221–225.
   PubMed Web of Science ®Google Scholar
• Boiardi A, Munari L, Milanesi I, et al. Impaired cardiovascular reflexes in cluster headache and migraine patients - evidence for an autonomic dysfunction. Headache. 1988;28(6):417–422.
   PubMed Web of Science ®Google Scholar
• Gass JJ, Glaros AG. Autonomic dysregulation in headache patients. Appl Psychophysiol Biofeedback. 2013;38(4):257–263.
   PubMed Web of Science ®Google Scholar
• Friedman BW, Garber L, Yoon A, et al. Randomized trial of IV valproate vs. metoclopramide vs. ketorolac for acute migraine. Neurology. 2014;82(11):976–983.
   PubMed Web of Science ®Google Scholar
• Secil Y, Unde C, Beckmann YY, et al. Blood pressure changes in migraine patients before, during and after migraine attacks. Pain Pract. 2010;10(3):222–227.
   PubMed Web of Science ®Google Scholar
• Cuomo-Granston A, Drummond PD. Migraine and motion sickness: what is the link? Prog Neurobiol. 2010;91(4):300–312.
   PubMed Web of Science ®Google Scholar
• Milovanovic DD, Majkic-Sing N, Mirkovic D, et al. Plasma and urinary serotonin and 5-hydroxyindol-3-acetic acid in adults with migraine and tension-type headache. Adv Exp Med Biol. 1999;467:191–197.
   PubMed Web of Science ®Google Scholar
• Parkman HP. Migraine and gastroparesis from a gastroenterologist’s perspective. Headache. 2013;53 Suppl 1:4–10.
   PubMed Web of Science ®Google Scholar
• Aurora SK, Papapetropoulos S, Kori SH, et al. Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications. Cephalalgia. 2013;33(6):408–415.
   PubMed Web of Science ®Google Scholar
• Chai NC, Shapiro RE, Rapoport AM. Why does vomiting stop a migraine attack? Curr Pain Headache R. 2013;17(9):362.
   PubMed Web of Science ®Google Scholar
• Martinson J. The effect of graded stimulation of efferent vagal nerve fibres on gastric motility. Acta Physiol Scand. 1964;62:256–262.
   PubMedGoogle Scholar
• Becker WJ. Acute migraine treatment in adults. Headache. 2015;55(6):778–793.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ. Multisensory integration in migraine. Curr Opin Neurol. 2013;26(3):248–253.
   PubMed Web of Science ®Google Scholar
• Vingen JV, Pareja JA, Storen O, et al. Phonophobia in migraine. Cephalalgia. 1998;18(5):243–249.
   PubMed Web of Science ®Google Scholar
• Zanchin G, Dainese F, Trucco M, et al. Osmophobia in migraine and tension-type headache and its clinical features in patients with migraine. Cephalalgia. 2007;27(9):1061–1068.
   PubMed Web of Science ®Google Scholar
• Stankewitz A, May A. Increased limbic and brainstem activity during migraine attacks following olfactory stimulation. Neurology. 2011;77(5):476–482.
   PubMed Web of Science ®Google Scholar
• Friedman DI, De ver Dye T. Migraine and the environment. Headache. 2009;49(6):941–952.
   PubMed Web of Science ®Google Scholar
• Main A, Vlachonikolis I, Dowson A. The wavelength of light causing photophobia in migraine and tension-type headache between attacks. Headache. 2000;40(3):194–199.
   PubMed Web of Science ®Google Scholar
• Noseda R, Bernstein CA, Nir RR, et al. Migraine photophobia originating in cone-driven retinal pathways. Brain. 2016;139:1971–1986.
   PubMed Web of Science ®Google Scholar
• Noseda R, Lee AJ, Nir RR, et al. Neural mechanism for hypothalamic-mediated autonomic responses to light during migraine. P Natl Acad Sci USA. 2017;114(28):E5683–E5692.
   PubMed Web of Science ®Google Scholar
• Cortez MM, Rea NA, Hunter LA, et al. Altered pupillary light response scales with disease severity in migrainous photophobia. Cephalalgia. 2017;37(8):801–811.
   PubMed Web of Science ®Google Scholar
• Noseda R, Kainz V, Borsook D, et al. Neurochemical pathways that converge on thalamic trigeminovascular neurons: potential substrate for modulation of migraine by sleep, food intake, stress and anxiety. PLoS One. 2014;9:8.
   PubMed Web of Science ®Google Scholar
• Noseda R, Borsook D, Burstein R. Neuropeptides and neurotransmitters that modulate thalamo-cortical pathways relevant to migraine headache. Headache. 2017;57:97–111.
   PubMed Web of Science ®Google Scholar
• Atasoy HT, Atasoy N, Unal AE, et al. Sympathetic skin response in migraineurs and patients with medication overuse headache. Headache. 2004;44(4):305–310.
   PubMed Web of Science ®Google Scholar
• Drummond PD. Disturbances in ocular sympathetic function and facial blood flow in unilateral migraine headache. J Neurol Neurosurg Psychiat. 1990;53(2):121–125.
   PubMed Web of Science ®Google Scholar
• Drummond PD, Lance JW. Facial temperature in migraine, tension-vascular and tension headache. Cephalalgia. 1984;4(3):149–158.
   PubMed Web of Science ®Google Scholar
• Drummond PD, Granston A. Facilitation of extracranial vasodilatation to limb pain in migraine sufferers. Neurology. 2003;61(1):60–63.
   PubMed Web of Science ®Google Scholar
• Drummond PD. The mechanism of facial sweating and cutaneous vascular responses to painful stimulation of the eye. Brain. 1992;115(Pt 5):1417–1428.
   PubMedGoogle Scholar
• Vijayalakshmi I, Nilima S, Bhatia M, et al. Evaluation of neurophysiological parameters: autonomic status and acute pain perception in migraneurs. Delhi Psychiat J. 2010;13(1):79–85.
   Google Scholar
• Barbanti P, Fabbrini G, Pesare M, et al. Unilateral cranial autonomic symptoms in migraine. Cephalalgia. 2002;22(4):256–259.
   PubMed Web of Science ®Google Scholar
• Arslan HH, Tokgoz E, Yildizoglu U, et al. Evaluation of the changes in the nasal cavity during the migraine attack. J Craniofac Surg. 2014;25(5):E446–E449.
   PubMed Web of Science ®Google Scholar
• Kinard KI, Smith AG, Singleton JR, et al. Chronic migraine is associated with reduced corneal nerve fiber density and symptoms of dry eye. Headache. 2015;55(4):543–549.
   PubMed Web of Science ®Google Scholar
• Barriga FJ, Lopez de Silanes C, Gili P, et al. Ciliary ganglioplegic migraine: migraine-related prolonged mydriasis. Cephalalgia. 2011;31(3):291–295.
   PubMed Web of Science ®Google Scholar
• Cambron M, Maertens H, Paemeleire K, et al. Autonomic function in migraine patients: ictal and interictal pupillometry. Headache. 2014;54(4):655–662.
   PubMed Web of Science ®Google Scholar
• Puledda F, Goadsby PJ. Current approaches to neuromodulation in primary headaches: focus on vagal nerve and sphenopalatine ganglion stimulation. Curr Pain Headache Rep. 2016;20(7):47.
   PubMed Web of Science ®Google Scholar
• Mojica J, Mo B, Ng A. Sphenopalatine ganglion block in the management of chronic headaches. Curr Pain Headache Rep. 2017;21(6):27.
   PubMed Web of Science ®Google Scholar
• Swaminathan A, Smith JH. Migraine and vertigo. Curr Neurol Neurosci Rep. 2015;15(2):515.
   PubMed Web of Science ®Google Scholar
• Van Stegeren A, Rohleder N, Everaerd W, et al. Salivary alpha amylase as marker for adrenergic activity during stress: effect of betablockade. Psychoneuroendocrino. 2006;31(1):137–141.
   PubMed Web of Science ®Google Scholar
• Rohleder N, Wolf JM, Maldonado EF, et al. The psychosocial stress-induced increase in salivary alpha-amylase is independent of saliva flow rate. Psychophysiology. 2006;43(6):645–652.
   PubMed Web of Science ®Google Scholar
• Bugdayci G, Yildiz S, Altunrende B, et al. Salivary alpha amylase activity in migraine patients. Auton Neurosci. 2010;155(1–2):121–124.
   PubMed Web of Science ®Google Scholar